US Revenue Cycle Management Market Size to Grow US$ 312 Billion By 2030

The US revenue cycle management market size was approximate at US$ 142.99 billion in 2022 and is anticipated to grow US$ 312  billion by 2030, registering a compound annual growth rate of 10.24% from 2022 to 2030.

The US revenue cycle management market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the US revenue cycle management market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the US revenue cycle management report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the US revenue cycle management market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/243

US Revenue Cycle Management Market Report Scope 

Also read: Ammonia Market Size to Grow US$ 129.63 Billion By 2030

Research Approach

The comprehensive report on the global US revenue cycle management market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global US revenue cycle management market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

• Allscripts Healthcare Solutions
• Change Healthcare Inc.
• Cognizant Technology Solutions Corp.
• Computer Programs and Systems Inc.
• Experian Plc
• Medical Information Technology Inc.
• MEDIREVV
• OSP Labs
• Quest Diagnostics Inc.
• R1 RCM Inc.

US Revenue Cycle Management Market Segmentations

By Product

• Software
• Services

By Type

• Integrated
• Standalone

By Function

• Product Development
• Member Engagement
• Network Management
• Care Management
• Claims Management
• Risk and Compliances

By Delivery Mode

• Web based
• Cloud based

By Physician Specialty

• Oncology
• Cardiology
• Anesthesia
• Radiology
• Pathology
• Pain Management
• Emergency Service
• Others

By Sourcing

• In-house
• External RCM Apps/ Software
• Outsourced RCM Services

By End User

• Physician Back office,
• Hospitals
• Diagnostic Laboratories
• Other

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Revenue Cycle Management Market 

5.1. COVID-19 Landscape: US Revenue Cycle Management Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global US Revenue Cycle Management Market, By Function

8.1. US Revenue Cycle Management Market, by Function, 2022-2030

8.1.1. Product Development

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Member Engagement

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Network Management

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Care Management

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Claims Management

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Risk and Compliances

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global US Revenue Cycle Management Market, By Product

9.1. US Revenue Cycle Management Market, by Product, 2022-2030

9.1.1. Software

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Services

Chapter 10. Global US Revenue Cycle Management Market, By Type 

10.1. US Revenue Cycle Management Market, by Type, 2022-2030

10.1.1. Integrated

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Standalone

Chapter 11. Global US Revenue Cycle Management Market, By Delivery Mode

11.1. US Revenue Cycle Management Market, by Delivery Mode, 2022-2030

11.1.1. Web based

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cloud based

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global US Revenue Cycle Management Market, By End User

12.1. US Revenue Cycle Management Market, by End User, 2022-2030

12.1.1. Physician Back office

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Diagnostic Laboratories

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Other

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global US Revenue Cycle Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.5. Market Revenue and Forecast, by End User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.7. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.8. Market Revenue and Forecast, by End User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.10. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Allscripts Healthcare Solutions

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Change Healthcare Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cognizant Technology Solutions Corp.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Computer Programs and Systems Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Experian Plc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Medical Information Technology Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. MEDIREVV

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. OSP Labs

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quest Diagnostics Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. R1 RCM Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global US revenue cycle management market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for US revenue cycle management are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com